Clinical Trial Update: Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT [Phase 4]

View source ↗

Summary

Clinical trial update on ATG for prophylaxis of acute graft-versus-host disease in matched sibling donor peripheral blood stem cell transplantation, Phase 4, co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• ATG (anti-thymocyte globulin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: aGVHD | Phase 4 | Status: COMPLETED